M
Michael J. Sullivan
Researcher at McMaster University
Publications - 11
Citations - 4027
Michael J. Sullivan is an academic researcher from McMaster University. The author has contributed to research in topics: Heart failure & Thallium. The author has an hindex of 7, co-authored 11 publications receiving 3881 citations.
Papers
More filters
Journal Article
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure
Gordon H. Guyatt,Michael J. Sullivan,Penelope J. Thompson,Ernest L. Fallen,S. O. Pugsley,D W Taylor,Leslie B. Berman +6 more
TL;DR: It is concluded that the 6-minute walk is a useful measure of functional exercise capacity and a suitable measure of outcome for clinical trials in patients with chronic heart failure.
Journal ArticleDOI
Effect of encouragement on walking test performance.
Gordon H. Guyatt,S. O. Pugsley,Michael J. Sullivan,Penelope J. Thompson,Leslie B. Berman,Norman L. Jones,Ernest L. Fallen,D W Taylor +7 more
TL;DR: The results demonstrate the need for careful standardisation of the performance of walking tests, and suggest caution in interpreting studies in which standardisation is not a major feature of the study design.
Journal ArticleDOI
How should we measure function in patients with chronic heart and lung disease
Gordon H. Guyatt,Penelope J. Thompson,Leslie B. Berman,Michael J. Sullivan,Marie Townsend,Norman L. Jones,S. O. Pugsley +6 more
TL;DR: It is suggested that exercise capacity in the laboratory can be differentiated from functional exercise capacity (the ability to undertake physically demanding activities of daily living) and that the walk test provides a good measure of function in patients with heart and lung disease.
Journal ArticleDOI
Development and testing of a new measure of health status for clinical trials in heart failure.
Gordon H. Guyatt,Sharon Nogradi,Susan Halcrow,Joel Singer,Michael J. Sullivan,Ernest L. Fallen +5 more
TL;DR: The authors develop a new measure of subjective health status for patients with heart failure that shows moderate correlations with patient global ratings, walk test scores, and clinical assessments of heart failure, and conclude that it may be useful for measuring health status in clinical trials in heart failure.
Journal ArticleDOI
A controlled trial of digoxin in congestive heart failure
Gordon H. Guyatt,Michael J. Sullivan,Ernest L. Fallen,Hirawan Tihal,Elizabeth Rideout,Susan Halcrow,Sharon Nogradi,Marie Townsend,D. Wayne Taylor +8 more
TL;DR: It was concluded that oral digoxin, in doses titrated to produce a serum level of 1.54 to 2.56 nmol/liter, improved quality of life and functional exercise capacity in some patients with CHF in sinus rhythm.